US7541141B2 - Method of Using Estrogen-Related Receptor Alpha (ERRα) Status to Determine Prognosis, Treatment Strategy and Predisposition to Breast Cancer, and Method of Using ERRα as a Therapeutic Target for the Treatment of Breast Cancer